Evidence map

ArticleTherapeutic advances in chronic disease2023

Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes.

Fang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36950020